Newsfeeds Archive - Page 2 of 17

2 minute read

GameStop Trader ‘Roaring Kitty’ Sparks Wall Street Rally In Heavily Shorted Stocks: What You Need To Know Right Now

May 13, 4:38 PM

The madness in meme stocks on Monday can be traced back to a social media post from Keith Gill, best known as "Roaring Kitty" on YouTube and X or "DeepF***ingValue" on Reddit. Several names with high short interest are ripping higher in the wake of the post. Yes, a simple meme has kicked off a buying frenzy in heavily shorted names.

ABIO

2 minute read

Movers

12 Consumer Discretionary Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

May 10, 12:31 PM

Gainers Sweetgreen (NYSE:SG) shares rose 35.7% to $31.98 during Friday’s regular session. The company’s market cap stands at…

CZOO

2 minute read

Movers

12 Consumer Discretionary Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

May 9, 4:31 PM

Gainers Funko (NASDAQ:FNKO) stock rose 13.6% to $7.75 during Thursday’s after-market session. The company’s market cap stands at…

COOK

2 minute read

Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

May 2, 5:43 AM

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) rose sharply in today’s pre-market trading after the company reported better-than-expected first-quarter…

APVO

2 minute read

Movers

12 Consumer Discretionary Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

April 29, 12:31 PM

Gainers Mullen Automotive (NASDAQ:MULN) shares increased by 36.7% to $4.32 during Monday’s regular session. The company’s market cap…

CZOO

1 minute read

Movers

11 Consumer Discretionary Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

April 29, 8:07 AM

Gainers SharpLink Gaming (NASDAQ:SBET) shares moved upwards by 19.2% to $1.24 during Monday’s pre-market session. The market value…

3 minute read

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Avi Kapoor

April 15, 2:11 PM

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

ADIL